| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 07/28/2009 | US7566567 nontumorigenic, virally-immortalized human hepatocyte cell lines, that can be maintained in serum-free media, and produce endogenous plasma proteins, such as albumin, alpha -1 antitrypsin, blood clotting factors VIII and IX, |
| 07/28/2009 | US7566445 Canister comprising container closed with metering valve, comprising pharmaceutical suspension aerosol formulation free of surfactant, which consists of salbutamol sulphate, ethanol, and 1,1,1,2-tetrafluoroethane; higher levels of ethanol have beneficial results |
| 07/23/2009 | WO2005034861A3 A dried biotherapeutic composition, uses, and device and methods for administration thereof |
| 07/23/2009 | US20090187023 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl))-piperidine-2,6-dione |
| 07/23/2009 | US20090186908 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 07/23/2009 | US20090186890 Pharmaceutical Formulation of Iressa Comprising a Water-Soluble Cellulose Derivative |
| 07/23/2009 | US20090186855 antagonists; oligopeptide of N-(3-indolylacetyl)-L-isoleucine and glycine; IBD, sepsis, periodontal disease, mucositis, acne, cardiovascular disease, COPD, arthritis, cystic fibrosis, infections, ischemia/reperfusion, asthma, stroke, brain injuries, enterocolitis, bed sores, leprosy, atopic dermatitis |
| 07/23/2009 | US20090186422 Peptide for use in the treatment of immunological defects and allergies; capable of inhibiting protein-protein interaction between calcineurin and NFAT |
| 07/23/2009 | US20090186363 Compositions and methods for the diagnosis and treatment of tumor |
| 07/23/2009 | US20090186104 Herbal compositions for the treatment of mucosal lesions |
| 07/23/2009 | US20090186085 Methods and Apparatus For Determining Formulation Orientation of Multi-Layered Pharmaceutical Dosage Forms |
| 07/23/2009 | US20090186056 Compositions and methods for preventing infection |
| 07/23/2009 | US20090186038 Methods of Preventing or Treating Respiratory Conditions |
| 07/23/2009 | US20090185978 Monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 07/22/2009 | EP2080521A1 Gastrin compositions and formulations, and methods of use and preparation |
| 07/22/2009 | EP1623714A4 Treatment kit which assists with antibiotic therapy for intracellular infectious diseases |
| 07/22/2009 | EP1597274B1 Hsp60 from arthrobacter |
| 07/22/2009 | EP1583499B1 A novel polyherbal preparation for the prevention of atherosclerosis and hyperlipidemia |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | CN101486766A Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 07/22/2009 | CN101486683A Pyridazinones and triazinones and medicinal use thereof |
| 07/22/2009 | CN100516034C Inhibitors of aspartyl protease |
| 07/22/2009 | CN100515420C Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 07/21/2009 | US7563896 Process of obtaining type II dehydroquinase enzyme inhibitors and precursors thereof |
| 07/21/2009 | US7563815 Benzamidazoles, compositions containing such compounds and methods of use |
| 07/21/2009 | US7563811 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents |
| 07/21/2009 | US7563803 M3 muscarinic acetylcholine receptor antagonists |
| 07/21/2009 | US7563777 Method to induce neovascular formation and tissue regeneration |
| 07/21/2009 | US7563473 purified plant protein is separated from solvent extraction; as food ingredients, infant formula ingredients, cosmetic ingredients, pet food ingredients, and animal feed supplements |
| 07/21/2009 | US7563466 Antiinflammatory agents for both viral and non-viral lesions |
| 07/21/2009 | US7563465 Jucara and Açai fruit-based dietary supplements |
| 07/21/2009 | CA2348988C Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor |
| 07/16/2009 | US20090182143 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 07/16/2009 | US20090182006 Treating a respiratory disorder by administering a hydrate of Gemifloxacinwith a carrier or excipient; chemical resistance; humidity; storage stability; thermodynamics; materials handling; sksin disorders; soft tissue-targeted therapy; sexual disorders; bovine mastitis; veterinary medicine |
| 07/16/2009 | US20090181988 Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof |
| 07/16/2009 | US20090181936 antiandrogen compounds, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal, and methods for their use in the prevention and treatment of conditions mediated by androgen receptors, such as prostrate cancer |
| 07/16/2009 | US20090181079 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 07/16/2009 | US20090181032 facilitate drug delivery of other molecules; e.g. use intraocularly in eye surgery, glaucoma, retinopathy treatments |
| 07/16/2009 | US20090181024 Novel composition and methods for the treatment of immune related diseases |
| 07/16/2009 | US20090181013 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/16/2009 | US20090181000 Methods for the Dietary Management of Irritable Bowel Syndrome and Carbohydrate Malabsorption |
| 07/16/2009 | US20090180961 Screening a candidate compound for antiinflammatory activity by administering the candidate in vivo to cells of an animal that express a Reso E receptor; reduced expression of interleukin-12 and reduced migration of dendritic cells into T-cell areas of the spleen indicates a good candidate |
| 07/15/2009 | EP1651190A4 Formulations containing an immune response modifier |
| 07/15/2009 | CN101481409A BASB027 proteins and genes from Moraxella catarrhalis, antigens, antibodies, and uses |
| 07/15/2009 | CN100512876C Coated metal pyrithione particles for treatment of microorganisms |
| 07/14/2009 | US7560488 orally administering 250 mg of 2',4'-difluoro-4-hydroxy-[1,1'-biphenyl]-3-carboxylic acid (Diflunisal) twice per day; for neuropathic pain, cardiomyopathy, amyloidosis, following liver transplantation |
| 07/14/2009 | US7560467 Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors |
| 07/14/2009 | US7560455 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 07/14/2009 | US7560444 Formulations comprising low molecular weight heparin and a therapeutic, prophylactic or diagnostic agent; improved bioavailability; side effect reduction |
| 07/14/2009 | US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy |
| 07/14/2009 | US7560116 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 07/14/2009 | CA2402988C Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent |
| 07/14/2009 | CA2262972C Compositions of plant carbohydrates as dietary supplements |
| 07/09/2009 | WO2005004791A3 Compounds and methods for the treatment and prevention of bacterial infection |
| 07/09/2009 | US20090176973 Thrombopoietin mimetics |
| 07/09/2009 | US20090176832 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 07/09/2009 | US20090176808 combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 07/09/2009 | US20090176752 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 07/09/2009 | US20090176746 4'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-3'-hydroxybiphenyl-4-carboxylic acid; Promotes thrombopoiesis and megakaryocytopoiesis |
| 07/09/2009 | US20090176307 Compounds, Compositions and Methods |
| 07/09/2009 | US20090175965 Antiscarring, antiaging, photodamaged skin or as a depilatory; unsaponifiable component from canola oil, rapeseed oil, sunflower oil, palm oil, maize oil, sesame oil, wheatgerm oil and one from avocado oil, lupin oil, or soybean oil |
| 07/09/2009 | US20090175853 Method for treating amyloid disease |
| 07/09/2009 | US20090175800 Methods and Compositions For P2X Receptor Calcium Entry Channels and Other Calcium Entry Mechanisms |
| 07/08/2009 | EP2077112A1 Methods and compositions using thalidomide for the treatment and management of cancers and idiopathic pulmonary fibrosis |
| 07/08/2009 | EP1691758A4 Nutraceutical mangosteen tea |
| 07/08/2009 | EP1682082A4 Electromagnetic field regulating compositions |
| 07/08/2009 | EP1682074A4 Compositions and methods for healthy pregnancy |
| 07/08/2009 | EP1660181B1 Treatment of age-related macular degeneration |
| 07/08/2009 | CN100509811C Azaindoles |
| 07/08/2009 | CN100509801C HIV inhibiting pyrimidines derivatives |
| 07/08/2009 | CN100508976C Orally dissolving films |
| 07/08/2009 | CN100508974C Transdermal patch for administering fentanyl |
| 07/07/2009 | US7557189 Immunoconjugates; screening for antibodies with improved affinity to CD 33 antigen; diagnosis of chronic myeloid leukemia (CML) and promyelocytic leukemia (PML); treating cancer |
| 07/07/2009 | US7557183 Polyethylene glycol linked GLP-1 compounds |
| 07/07/2009 | US7557143 Such as 3,5-Dibromo-4-(4-hydroxy-3-phenethylcarbamoyl-phenoxy)-phenyl acetic acid; metabolism regulation agents; avoiding cardiovascular and other toxicities of hormones |
| 07/07/2009 | US7557115 Compounds for modulation of kinesins as anticancer agents with administering |
| 07/07/2009 | CA2519175C A method of treating a systemic disease |
| 07/07/2009 | CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 07/02/2009 | US20090170896 c-Met modulators and methods of use |
| 07/02/2009 | US20090169587 Chronotherapeutic dosage forms |
| 07/02/2009 | US20090169559 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 07/01/2009 | EP1565208B1 The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP0973492B1 Antiperspirant stick with improved characteristics |
| 07/01/2009 | CN101468965A Biaryl substituted 6-membered heterocyles as sodium channel blockers |
| 07/01/2009 | CN100506999C Optimized expression of HPV 31 L1 in yeast |
| 06/30/2009 | US7553913 Comprised of ethylene oxide and one or more other alkylene oxide(s); superior properties for medical and surgical applications; biocompatibility, substantial non-toxicity, water solubility, desirable handling properties (e.g., hardness, ductility, malleability) |
| 06/30/2009 | US7553494 WT1 fusion proteins |
| 06/30/2009 | CA2418963C Epilatory compositions comprising particulate fumed silica |
| 06/25/2009 | WO2005032482A3 Treatment of demyelinating autoimmune disease with modified ordered peptides |
| 06/25/2009 | US20090163721 Crystalline solids of carvedilol and processes for their preparation |
| 06/25/2009 | US20090163543 Histone Deacetylase Inhibitors and Methods of Use Thereof |
| 06/25/2009 | US20090162433 Method of treatment |
| 06/25/2009 | US20090162404 Tumor vaccine |
| 06/25/2009 | US20090162331 Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
| 06/24/2009 | EP1565198A4 Anti-angiogenesis effects of morinda citrifolia |
| 06/24/2009 | CN101466357A Direct cellular energy delivery system |
| 06/24/2009 | CN100504385C Methods for analyzing tissue specimen by biological map |
| 06/24/2009 | CN100502847C Compositions containing substituted quinolines and substituted diphenyl sulfones and its pharmaceutical use |
| 06/24/2009 | CN100502845C Compounds for treating and preventing exercise-induced cardiac arrhythmias and its preparation method |